ArticleFrontiers in pharmacology2025

Case Report: Second-line favourable effect of pembrolizumab plus chemotherapy in a patient with metastatic hepatoid adenocarcinoma of the stomach.

Yao Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.